Dozens of studies demonstrate the clear link between estrogen metabolism genes and breast cancer.  This cutting edge test of 8 genes is now available to physicians and allows for precision in prescribing hormonal replacement, bio-identicals, fertility medications and even birth control pills for some women. Studies show that women with mutations on 3 or more genes have elevated potentially cancerous estrogen levels which may result in as much as 13 times greater breast cancer risk.

The Estrogene Test is a powerful physician tool in breast cancer prevention.

Healthy women have variations on no more than 2 estrogen metabolism genes. Their estrogen levels are normal. Women with breast cancer have variations on 3 or more genes have higher levels of toxic estrogens. The profile of women at high risk, is very similar to that of women with breast cancer.


In a 10 year ongoing study at the Institute for Individualized Medicine, 175 women with either ER+ breast cancer or at high risk with toxic estrogen levels,  have not had a recurrence or developed breast cancer by following gene specific protocols to alter their gene expression. Read more >